» Articles » PMID: 35394497

Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021

Overview
Journal JAMA
Specialty General Medicine
Date 2022 Apr 8
PMID 35394497
Authors
Affiliations
Soon will be listed here.
Citing Articles

Update on outpatient antibiotic prescribing during the COVID-19 pandemic: United States, 2020-2022.

Bizune D, Gouin K, Powell L, Hersh A, Hicks L, Kabbani S Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e193.

PMID: 39483328 PMC: 11526179. DOI: 10.1017/ash.2024.398.


Impact of a package of point-of-care diagnostic tests, a clinical diagnostic algorithm and adherence training on antibiotic prescriptions for the management of non-severe acute febrile illness in primary health facilities during the COVID-19....

Kiemde F, Nkeramahame J, Ibarz A, Dittrich S, Olliaro P, Valia D BMC Infect Dis. 2024; 24(1):870.

PMID: 39192209 PMC: 11351252. DOI: 10.1186/s12879-024-09787-y.


Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals.

Giacomelli A, Ciubotariu C, Zacheo M, Rabbione A, Pieruzzi M, Barone F Viruses. 2024; 16(7).

PMID: 39066168 PMC: 11281468. DOI: 10.3390/v16071005.


Incidence of secondary bacterial infections and risk factors for in-hospital mortality among coronavirus disease 2019 subjects admitted to secondary care hospital: A single-center cross-sectional retrospective study.

Sannathimmappa M, Marimuthu Y, Al Subhi S, Al Bathari F, Al Balushi M, Al Ghammari S Int J Crit Illn Inj Sci. 2024; 14(2):94-100.

PMID: 39005973 PMC: 11245142. DOI: 10.4103/ijciis.ijciis_71_23.


Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the COVID-19 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.

Chua K, Fischer M, Rahman M, Linder J Clin Infect Dis. 2024; 79(2):312-320.

PMID: 38648159 PMC: 11327783. DOI: 10.1093/cid/ciae135.


References
1.
. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021; 397(10279):1063-1074. PMC: 7972318. DOI: 10.1016/S0140-6736(21)00461-X. View

2.
King L, Tsay S, Hicks L, Bizune D, Hersh A, Fleming-Dutra K . Changes in outpatient antibiotic prescribing for acute respiratory illnesses, 2011 to 2018. Antimicrob Steward Healthc Epidemiol. 2022; 1(1):1-8. PMC: 9345578. DOI: 10.1017/ash.2021.230. View

3.
Gerber J, Prasad P, Russell Localio A, Fiks A, Grundmeier R, Bell L . Racial differences in antibiotic prescribing by primary care pediatricians. Pediatrics. 2013; 131(4):677-84. PMC: 9923585. DOI: 10.1542/peds.2012-2500. View

4.
Kow C, Hasan S . Use of Azithromycin in COVID-19: A Cautionary Tale. Clin Drug Investig. 2020; 40(10):989-990. PMC: 7438973. DOI: 10.1007/s40261-020-00961-z. View

5.
Oldenburg C, Pinsky B, Brogdon J, Chen C, Ruder K, Zhong L . Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial. JAMA. 2021; 326(6):490-498. PMC: 8285753. DOI: 10.1001/jama.2021.11517. View